| Literature DB >> 20970386 |
Antonella Cuzzola1, Edoardo Ferlazzo, Domenico Italiano, Rocco Salvatore Calabrò, Placido Bramanti, Pierre Genton.
Abstract
Lennox-Gastaut syndrome is an intractable epileptic encephalopathy, with most patients experiencing daily seizures despite therapy with multiple antiepileptic drugs. New treatments need to be tested to define their efficacy in this syndrome. Lacosamide is a new antiepileptic drug recently approved for the treatment of partial-onset seizures. We describe three patients with Lennox-Gastaut syndrome resistant to conventional antiepileptic drugs whose seizures were aggravated by lacosamide.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20970386 DOI: 10.1016/j.yebeh.2010.09.024
Source DB: PubMed Journal: Epilepsy Behav ISSN: 1525-5050 Impact factor: 2.937